TTP Company Updates | Glassdoor.co.uk

Company Updates

  • No pain, no gain. Arnau Perdigó-Oliveras looks at the R&D challenges facing microneedle systems and the exciting new prospects for drug delivery and mulitplex biomarker detection. #thespacetoinvent

    No pain, no gain: R&D challenges for the success of microneedle systems - TTP

    Microneedle systems pose multidisciplinary R&D challenges-some because of and some despite the much smaller size of the needles involved. But microneedle systems also offer exciting new prospects for drug delivery and multiplex biomarker detection. This information could be used to guide personalised treatment or enable value-based healthcare.

  • In our concept paper Satellite at the Edge, Adrian Hillier, extolled the virtues of an edge-centric approach to Satellite IoT. Now we set out the “why” by outlining four major benefits #thespacetoinvent #4minread #satellite http://glassdoor.com/slink.htm?key=vQOzw

    4 Benefits Satellite Operators and their Customers gain from an Edge-Centric Approach to the Industrial IoT - TTP

    In our concept paper "Satellite at the Edge", we extolled the virtues of an edge-centric approach to Satellite IoT. Having described the "what", we now set out the "why" by outlining four major benefits and asking whether they primarily advantage satellite network operators or their customers.

Work at TTP? Share Your Experiences

TTP
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or